FDA Investigator Gary J Lehr
Gary J Lehr has inspections in 1 countries as of 10 Oct 2023. Gary J Lehr has collaborated with a combined 1722 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
32
Last Inspection Date:
10 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alice S Tsao,
Althea A Williams,
Amatul H Marium,
Amy W Mai,
Amy W Yan Mai,
Andrew M Abramowitz,
Ann M Stewart,
Avital A Shimanovich,
Bijoy Panicker,
Brandy N Lepage,
Brenda W Uratani, PhD,
Charanjeet Jassal,
Charisse K Green,
Daniel L Zheng,
David R Delucia,
Demitria J Xiradakis,
Dennis E Guilfoyle, PhD,
Dongping Dai, PhD,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Edouard Viard,
Erik W Koester,
Felix Maldonado,
Frank Verni,
Gam S Zamil,
Gary J Lader,
Gary T Greco,
Guerlain Ulysse,
Helen B Ricalde,
Irina Gaberman,
Jaison J Eapen,
James A Liubicich,
James A Liubieich,
Jay T Wong,
Jazmine N Brown,
Jazmine N Still,
Jose O Hernandez,
Joy P Matthias,
Juan Rjimenez Garcia,
Juanita P Versace,
Justin A Boyd,
Karen L Kosar,
Karishma G Gopaul,
Kazi Rafiquzzaman,
Kenneth H Williams,
Kevin A Gonzalez,
Kim Lthomas Cruse,
Kim Thomasc Rice,
Kimberly Y Smithson,
Krishna Ghosh, PhD,
Lawrence W Farina,
Marie Bbuen Bigornia,
Michael A Charles,
Michael Levin,
Mindy M Chou,
Nariman Patenaude,
Nazmul Hassan,
Neil J Bonzagni, PhD MPH,
Nerizza B Guerin,
Nicholas A Violand,
Omadevi Somai, Investigator,
Parul M Patel,
Patrick C Klotzbuecher,
Paul Mouris,
Peter Abel,
Peter Caparelli,
Peter R Caparelli,
Philip F Istafanos, DMV, MS,
Rachael A Moliver,
Ramon A Hernandez,
Rober C Horan, PhD,
Robert C Steyert,
Rochelle K Kimmel,
Samina S Khan,
Sarah A Meehan,
Sarah A Wangseng,
Satheesh Thomas,
Shari L Kahn,
Simone E Pitts,
Sony Mathews,
State Agency,
Steven M Weinman,
Susan M Joseph,
Susan W Ting,
Susant Hadman,
Suwaskie S Smith,
Tanya R Syffrard,
Terry Bridgewater,
Thomas J Arista,
Thomas J Mooney,
Thomas S Arista,
Tracy M Portelli,
Uduak M Inokon,
Valentino Fiorella,
Valerie A Potopsingh,
Vioela J Caze,
Xiaokuang Lai, PhD
Gary J Lehr's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more